Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma

机译：动脉内化疗联合玻璃体内美法仑治疗晚期单侧视网膜母细胞瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To evaluate the efficacy and safety of combined intra-arterial chemotherapy (IAC) and intravitreal melphalan (IVM) for the treatment of advanced unilateral retinoblastoma.

机译：评估联合动脉内化疗（IAC）和玻璃体内美法仑（IVM）治疗晚期单侧视网膜母细胞瘤的疗效和安全性。

著录项

期刊名称 International Journal of Ophthalmology
作者
Ting-Yi Liang; Xiu-Yu Zhu; Xu-Ming Hua; Xun-Da Ji; Pei-Quan Zhao;
展开▼
作者单位

展开▼
年(卷),期 2020(13),2
年度 2020
页码 -1
总页数 6
原文格式 PDF
正文语种
中图分类眼科学;
关键词
intra-arterial chemotherapy; intravitreal chemotherapy; melphalan; retinoblastoma; advanced stage; unilateral disease;

机译：动脉内化疗;玻璃体内化疗;美法仑;视网膜母细胞瘤;晚期;单侧疾病;

相似文献

外文文献
中文文献
专利

1. Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma [J] . Industrial and organizational psychology . 2020,第2期

机译：组合动脉内化疗和玻璃体内母酚用于治疗晚期单侧视网膜母细胞瘤
2. Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma [J] . Ting-Yi Liang, Xiu-Yu Zhu, Xu-Ming Hua, 国际眼科杂志：英文版 . 2020,第002期

机译：动脉内化疗联合玻璃体内美法仑治疗晚期单侧视网膜母细胞瘤
3. Combined Melphalan/Topotecan intra-arterial chemotherapy (MT-IAC) for salvage in retinoblastoma relapse following melphalan intra-arterial chemotherapy (M-IAC) [J] . Manassero Anthony, Gaillard Marie-Claire, Stathopoulos Christina, Investigative ophthalmology & visual science . 2016,第12期

机译：组合Melphalan / Topotecan内动脉化疗（MT-IAC）在Melphalan内 - 动脉化疗后视网膜母细胞瘤复活中的校存（M-IAC）
4. A SINGLE-CENTER EXPERIENCE USING CHEMOTHERAPY WITH MELPHALAN-DEXAMETHASONE (M-DEX) IN PATIENTS WITH AL AMYLOIDOSIS AND ADVANCED ORGAN INVOLVEMENT NOT ELIGIBLE FOR HIGH-DOSE MELPHALAN THERAPY (HDM) [C] . U. Hegenbart, T. Bochtler, J.B. Dengler, International Symposium on Amyloidosis . 2008

机译：使用化学疗法的单中心经验与Melphalan-Dexamethasone（M-DEX）的Al淀粉样蛋白病和先进器官参与没有资格获得高剂量Melphalan治疗（HDM）
5. Clinical Comparison of Chemotherapy Regimens to Treat Advanced Retinoblastoma: Intra-Arterial and Intravitreal Chemotherapy Versus Intra-Arterial and Intravenous Chemotherapy [D] . Fine, Jessica. 2018

机译：化学疗法治疗晚期视网膜母细胞瘤的临床比较：动脉内和玻璃体内化疗与动脉内和静脉内化疗
6. Fluorescein angiography findings in both eyes of a unilateral retinoblastoma case during intra-arterial chemotherapy with melphalan [O] . Cem Ozgonul, Neeraj Chaudhary, Raymond Hutchinson, 2019

机译：单侧成视网膜细胞瘤病例在美法仑的动脉内化疗期间双眼的荧光素血管造影结果
7. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment. [O] . Munier, F.L., Mosimann, P., Puccinelli, F., 2017

机译：单侧散发性D组视网膜母细胞瘤的一线动脉内或静脉内化疗：回顾性研究20年来的治疗，证明了较好的视觉效果，眼存活率和较短的成功率。

Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma

摘要

著录项

相似文献

相关主题

期刊订阅